What they were paid
Astria Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $49,000 | $0 | $86,980 | $0 | $135,980 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Astria Therapeutics, Inc. DEF 14A filed April 28, 2025, accession 0001104659-25-040180, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024Astria Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2024 · as the proxy prints themCompensation · Nominating/Governance
The rest of the Astria Therapeutics board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Gregg Lapointe | Independent Director | $146,980 |
| Hugh Cole | Independent Director | $135,730 |
| Jill C. Milne | Director | $0 |
| Joanne Beck | Independent Director | $139,480 |
| Jonathan Violin | Independent Director | $141,980 |
| Kenneth Bate | Chair of the Board | $177,480 |
| Michael Kishbauch | Independent Director | $140,980 |
| Sunil Agarwal | Independent Director | $256,282 |
The full Astria Therapeutics compensation record
free company briefThis page is one director within Astria Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat